IThB3
In-House 340B Pharmacy: A Strategy for Financial and Clinical Excellence
Date
November 3, 2016
The 340B Drug Discount Program provides an excellent opportunity for health centers to improve access to affordable prescription medication for their patients. Of the three basic models for implementing 340B pharmacy services, the community health center owned and operated "in-house" model offers the best opportunity to integrate clinical pharmacy into the primary care medical home model, with the added benefit of a positive financial impact for the health center. An added value of the in-house pharmacy model is flexibility in serving health center patients and control of the compliance framework. Despite these attributes, many health centers hesitate to consider implementing in-house pharmacy due to concerns about investment, planning, and operational challenges. This program will detail the value of an in-house pharmacy, provide a comprehensive guide to planning and implementing an in-house pharmacy including guidelines for space, equipment and staffing, and discuss strategies for operational success including clinical integration and the impact on patient outcomes. Woven throughout this session will be real-life health center examples.
- Evaluate the financial contribution and added value of in-house 340B pharmacy services.
- Develop a strategic and operational plan for implementing and operating an in-house 340B pharmacy.
- Understand the infrastructure and compliance framework necessary for operating an in-house 340B pharmacy.
Speaker
Sue Veer, MBA
President and CEO, Carolina Health Centers, Inc.
Tracks
Related Products
340B Medicaid Pharmacy Reimbursement: Trends, Risks, and Opportunities for the Health Center C-Suite
In order to comply with the CMS Covered Outpatient Drug Rule, states have implemented a variety of strategies to establishing 340B Medicaid policy through state plan amendments (SPAs)…
340B Policy Updates
Speakers will provide updates on the most recent policy developments in the 340B space, including on the Hill, at HRSA, and in the field…
340B: Developments in Policy and Reimbursement
Speakers will provide updates on the most recent policy and reimbursement developments in the 340B space, including on the Hill, at HRSA, in states, and in contracting…
340B: Where Are We Now, and Where Are We Going?
Speakers will provide updates on the most recent developments in the 340B space, including strategies to respond. Topics will include activities on the Hill, at HRSA, among manufacturers and contractors, and in the field…
